Laparoscopic hysterectomy vs abdominal hysterectomy
- Surgical approach to hysterectomy for benign gynaecological disease 2023 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 618 participantsLow
It is very uncertain whether laparoscopic hysterectomy changes long‐term outcomes compared with abdominal hysterectomy (very low certainty).
Laparoscopic hysterectomy showed no clear difference in long‐term complications (dichotomous) compared with abdominal hysterectomy (low certainty).
Laparoscopic hysterectomy showed no clear difference in intra‐operative visceral injury(dichotomous) compared with abdominal hysterectomy (low certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in perioperative mortality (within 1 month after operation) compared with no RIPC (moderate certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in myocardial infarction (within 1 month after operation) compared with no RIPC (moderate certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in renal impairment (within 1 month after operation) compared with no RIPC (moderate certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in stroke (within 1 month after operation) compared with no RIPC (moderate certainty).
Remote ischaemic preconditioning (RIPC) showed no clear difference in limb loss (within 1 month after operation) compared with no RIPC (low certainty).
Totally percutaneous showed no clear difference in short‐term mortality (30‐day or in‐hospital) compared with cut‐down femoral artery access (low certainty).
Totally percutaneous showed no clear difference in failure of aneurysm exclusion( compared with cut‐down femoral artery access (moderate certainty).
Totally percutaneous showed no clear difference in wound infection (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
Totally percutaneous showed no clear difference in major complications (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
Totally percutaneous showed no clear difference in medium‐ to long‐term complications( compared with cut‐down femoral artery access (moderate certainty).
Totally percutaneous showed no clear difference in bleeding complications (30‐day or in‐hospital) compared with cut‐down femoral artery access (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.